Print

Polydex Pharmaceuticals (POLXF) Reports Continued Robust Sales and Continued Earnings; Facility Improvements to Reduce Production Costs  
9/16/2013 9:27:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink:POLXF) (the "Company") reports that it has continued to experience high demand for product from its customers, resulting in increasing sales and collaborated investments into production upgrades and planned capital improvements.

Help employers find you! Check out all the jobs and post your resume.

//-->